We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Fluidigm

Fluidigm Corporation focuses on the most pressing needs in translational and clinical research, including cancer, imm... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Immune Cell Profiling Assay Boosts Use of Mass Cytometry

By LabMedica International staff writers
Posted on 09 May 2019
Print article
Image: The Helios CyTOF mass cytometry platform (Photo courtesy of Fluidigm).
Image: The Helios CyTOF mass cytometry platform (Photo courtesy of Fluidigm).
A new, multiplexed, antibody-based assay for immune cell profiling on its mass cytometry platform has been launched.

The assay is comprised of a single-tube assay pre-loaded with 30 metal-labeled antibodies that target common immune cell protein markers and a custom-developed software analyzer that can identify 37 immune cell types.

The assay is produced by Fluidigm (South San Francisco, CA, USA) is designed to run on its Helios CyTOF platform and said it expects the product to drive instrument placements and appeal to laboratories with existing Helios instruments, especially academic core facilities. The firm added that the assay offers great consistency, demonstrated in an early-access program that involved six sites.

The highly multiplexed 30-marker antibody panel was developed with input from expert immunologists in academia and biopharma and builds on the panels designed by the Human ImmunoPhenotyping Consortium. The panel was designed using industry-proven antibody clones, this assay provides the broadest single-tube view of the immune system from each precious sample. While the Maxpar Direct Immune Profiling Assay provides excellent immune cell coverage, one can easily add up to seven new antibodies to support the study goals. Because mass cytometry has limited channel crosstalk and a broad detection range, the expansion of high-parameter panels is simplified, a significant advantage over fluorescence cytometry.

Peter Betzelos, Fluidigm’s senior VP of global marketing, said, “For immune profiling core laboratoriess, they see this as a way they can access more investigators. In networks with a single core lab, the assay provides highly reproducible results with samples coming from multiple investigators. A standard solution that they can they easily customize by adding up to seven additional antibodies. They can share this product offering within their institution and beyond to their networks. Given its consistency run to run and site to site, it is also an ideal solution for large multi-cohort or multi-site studies.”


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.